Similar articles

• Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol.

  Passa P, Tugaye A, Gauville C, Canivet J. Passa P, et al. Diabete Metab. 1981 Sep;7(3):155-9. Diabete Metab. 1981. PMID: 7033007
• [Effects of new beta receptor blocking agent Acebutolol in patients with essential, renal, and broderline hypertension].

  Werning C. Werning C. Med Welt. 1977 Sep 30;28(39):1564-6. Med Welt. 1977. PMID: 22016 Clinical Trial. German. No abstract available.
• Adverse effects of antihypertensive drug therapy on glucose intolerance.

  Houston MC. Houston MC. Cardiol Clin. 1986 Feb;4(1):117-35. Cardiol Clin. 1986. PMID: 2871931 Review.
• [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].

  Kukes VG, Ostroumova OD, Mamaev VI, Batutina AM, Abakumov IuE, Zykova AA. Kukes VG, et al. Ter Arkh. 2003;75(8):43-7. Ter Arkh. 2003. PMID: 14520850 Clinical Trial. Russian.
• [Therapy of arterial hypertension in diabetic patients. When to start the treatment and which drugs to use?].

  Romanò M, Baldini MR. Romanò M, et al. Minerva Med. 1992 Nov;83(11):725-30. Minerva Med. 1992. PMID: 1361040 Review. Italian.